Benefits of a novel automated digital platform to support cancer survivorship.

Authors

Dinesh Kotak

Dinesh Kotak

Department of Hematology Oncology, The Permanente Medical Group, Roseville, CA

Dinesh Kotak, Jake Marjama, Marc Flagg, Jessica Sanchez, Amber Swanson, Laura Adams, Derrick McCray, Kevin Benson, Tatjana Kolevska

Organizations

Department of Hematology Oncology, The Permanente Medical Group, Roseville, CA, The Permanente Medical Group, Roseville, CA, The Permanente Medical Group, Oakland, CA, The Permanente Medical Group, Pleasanton, CA, Kaiser Permanente, Pleasanton, CA

Research Funding

No funding received
None.

Background: Advances in treatment and early diagnosis have led to an increase in the 5-year relative survival rate for patients diagnosed with cancer. As of January 2022, there were 18.1 million cancer survivors in the United States, reflecting 5.4% of the total population. This number is projected to increase by 24.4%, to 22.5 million by 2032 (Cancer Facts and Figures 2023- American Cancer Society). Survivorship program needs include surveillance, member/ patient engagement, lifestyle changes and symptom management. Survivorship appointments make up >50% of the total return visits in oncology. There is a dire need for easy-to-use technology tools to help deliver high-quality survivorship care. Methods: We developed rules to automatically create a cohort of patients with Stage II and III colon cancer. The surveillance plan was developed by experts based on national guidelines. A separate set of rules drives the automatic generation of due dates for all elements of the care plan including laboratory tests, radiology examinations and clinical evaluations. A real-time dashboard clearly shows the care gaps. Tools were added to the dashboard to help with task completion. Results: The platform was successfully rolled out to 21 medical centers in Kaiser Permanente Northern California, an integrated healthcare system providing care for 4.4 million members. We experienced an increase in the completion for each of the surveillance elements needed for patients. Laboratory tests increased by 12.5%, radiology examinations by 8%, and clinical evaluations by 16%. Results have been sustained over the first year of use. Conclusions: We have successfully developed and operationalized a digital platform to sustainably support survivorship. This platform automatically identifies our survivorship cohort, informs the care team when care gaps exist and provides tools for task completion. Our care teams have used this platform successfully to outreach patients to ensure timely surveillance. This automatic platform reduces manual, redundant tasks previously performed by the care team. Further research is needed to explore the potential for this systems-based approach to reduce disparities in care. We plan to expand this to other cancers. Planned enhancements include automatic member reminders, lifestyle recommendations and symptom management.

MonthNumber of patientsCEA - % timely completionCT Scan - % timely completionVisit - % timely completion
3/221336788673
9/221347919489
3/231505869181
6/231546889183

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Abstract Details

Meeting

2023 ASCO Quality Care Symposium

Session Type

Poster Session

Session Title

Poster Session A

Track

Quality, Safety, and Implementation Science,Cost, Value, and Policy,Patient Experience,Survivorship

Sub Track

Care Coordination, Cost, and Education

Citation

JCO Oncol Pract 19, 2023 (suppl 11; abstr 482)

DOI

10.1200/OP.2023.19.11_suppl.482

Abstract #

482

Poster Bd #

L8

Abstract Disclosures

Similar Abstracts

First Author: Hira Latif

First Author: Michelle Payan

Abstract

2022 ASCO Quality Care Symposium

Shift in survivorship care delivery.

First Author: Elizabeth Boutin McGrath